The DSM Annual General
Meeting of Shareholders on 7 May 2014 passed a resolution to
declare a dividend for 2013 of €1.65 per ordinary share of €1.50
par value. An interim dividend of €0.50 per ordinary share having
been paid on 29 August 2013, the final dividend for 2013 will
amount to €1.15 per ordinary share. With the passing of the resolution by the AGM, and in line
with DSM's policy to provide a stable and preferably rising
dividend, 2013 marks the fourth consecutive year DSM's dividend has
been increased.
This final dividend of €1.15 will be paid out in
cash or in the form of ordinary shares at the option of the
shareholder. Dividend in cash will be paid after deduction of 15%
Dutch dividend withholding tax. The ex-dividend date on NYSE
Euronext will be 9 May 2014 and the record date will be 13 May
2014.
Shareholders have from 14 May until 27 May 2014
(3.00 pm CET) to indicate their choice. On 28 May 2014 after the
close of trading on NYSE Euronext the number of dividend rights of
ordinary shares entitling the holder to one ordinary share will be
determined.
This exchange ratio will be based on the volume
weighted average price of all ordinary shares in DSM traded at NYSE
Euronext on 21 May 2014 up to and including 27 May 2014. The value
of the stock dividend will be virtually equal to the value of the
cash dividend. The ordinary shares that constitute the stock
dividend are entitled to any dividend for the financial year 2014
and to the dividends for subsequent financial years. Stock dividend
rights will not be traded on NYSE Euronext.
The following timetable applies:
9 May 2014:
Ex-dividend quotation
13 May 2014:
Record Date
14 May 2014 - 27 May 2014(3.00 pm CET):
Period in which shareholders can indicate their choice
28 May 2014 (COB):
Announcement of the exchange
ratio
3 June 2014:
Delivery of shares or cash payment
DSM - Bright Science.
Brighter Living.(TM)
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in
Life Sciences and Materials Sciences DSM is driving economic
prosperity, environmental progress and social advances to create
sustainable value for all stakeholders simultaneously. DSM delivers
innovative solutions that nourish, protect and improve performance
in global markets such as food and dietary supplements, personal
care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM's 24,500 employees deliver annual net sales of
around €10 billion. The company is listed on NYSE Euronext. More
information can be found at www.dsm.com.
Or find us on:
For more
information:
DSM
Corporate Communications Herman Betten
tel. +31 (0) 455782017
e-mail media.contacts@dsm.com |
DSM
Investor Relations Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com |
Press release-pdf
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1783576
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024